These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 20387006)

  • 41. Hypertension in spontaneously hypertensive rats occurs despite low plasma levels of homocysteine.
    Kondziella D; Zetterberg H; Haugen E; Fu M
    Physiol Res; 2008; 57(3):487-490. PubMed ID: 17298201
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
    Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase.
    Yang G; Wu L; Jiang B; Yang W; Qi J; Cao K; Meng Q; Mustafa AK; Mu W; Zhang S; Snyder SH; Wang R
    Science; 2008 Oct; 322(5901):587-90. PubMed ID: 18948540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Induction of oxidative stress by homocyst(e)ine impairs endothelial function.
    Mujumdar VS; Aru GM; Tyagi SC
    J Cell Biochem; 2001; 82(3):491-500. PubMed ID: 11500925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
    Weiss N; Keller C; Hoffmann U; Loscalzo J
    Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Homocysteine and glutathione peroxidase-1.
    Lubos E; Loscalzo J; Handy DE
    Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Implications of oxidative stress and homocysteine in the pathophysiology of essential hypertension.
    Rodrigo R; Passalacqua W; Araya J; Orellana M; Rivera G
    J Cardiovasc Pharmacol; 2003 Oct; 42(4):453-61. PubMed ID: 14508229
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyperhomocysteinemia: an additional risk factor in white coat hypertension.
    Curgunlu A; Karter Y; Uzun H; Aydin S; Ertürk N; Vehid S; Simsek G; Kutlu A; Oztürk E; Erdine S
    Int Heart J; 2005 Mar; 46(2):245-54. PubMed ID: 15876808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Homocysteine--a risk factor for atherosclerosis].
    Debreceni L
    Orv Hetil; 2001 Jul; 142(27):1439-44. PubMed ID: 11481906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hyperhomocysteinemia--a risk factor for development of occlusive vascular diseases].
    Milosević-Tosić M; Borota J
    Med Pregl; 2002; 55(9-10):385-91. PubMed ID: 12584890
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Arrhythmia and neuronal/endothelial myocyte uncoupling in hyperhomocysteinemia.
    Rosenberger D; Moshal KS; Kartha GK; Tyagi N; Sen U; Lominadze D; Maldonado C; Roberts AM; Tyagi SC
    Arch Physiol Biochem; 2006; 112(4-5):219-27. PubMed ID: 17178594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Homocysteine, a Risk Factor for Cardiovascular Disease.
    Prasad K
    Int J Angiol; 1999 Jan; 8(1):76-86. PubMed ID: 9826415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperhomocysteinemia induces renal hemodynamic dysfunction: is nitric oxide involved?
    Fischer PA; Dominguez GN; Cuniberti LA; Martinez V; Werba JP; Ramirez AJ; Masnatta LD
    J Am Soc Nephrol; 2003 Mar; 14(3):653-60. PubMed ID: 12595501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hydrogen sulfide in hemostasis: friend or foe?
    Olas B
    Chem Biol Interact; 2014 Jun; 217():49-56. PubMed ID: 24746521
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin.
    Perna AF; Zacchia M; Trepiccione F; Ingrosso D
    Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28075397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of hydrogen sulfide and homocysteine transsulfuration pathway in the progression of kidney fibrosis after ureteral obstruction.
    Jung KJ; Jang HS; Kim JI; Han SJ; Park JW; Park KM
    Biochim Biophys Acta; 2013 Dec; 1832(12):1989-97. PubMed ID: 23846016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca
    Ji XW; Lyu HJ; Zhou GH; Wu B; Zhu YY; Wu TH; Zhang F; Jin SN; Cho KW; Wen JF
    Phytomedicine; 2021 Jan; 81():153410. PubMed ID: 33285470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
    Fridman O
    Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hyperhomocysteinemia and atherothrombotic disease.
    de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
    Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.